131I-6β-iodomethyl-19-norcholesterol SPECT/CT for primary aldosteronism patients with inconclusive adrenal venous sampling and CT results

Journal of Nuclear Medicine

Volumn 50, Issue 10, 2009, Pages 1631-1637

  Yen, Ruoh Fang ^a   Wu, Vin Cent ^a   Liu, Kao Lang ^a   Cheng, Mei Fang ^a   Wu, Yen Wen ^a   Chueh, Shih Chieh ^b   Lin, Wei Chou ^a   Wu, Kwan Dun ^a   Tzen, Kai Yuan ^a   Lu, Ching Chu ^a   Lin, Yen Hung ^c   Ho, Yi Luwn ^c   Chang, Hung Wei ^c   Lin, Lian Yu ^c   Hu, Fu Chang ^c   Wang, Shuo Meng ^c   Huang, Kuo How ^c   Chen, Yung Ming ^c   Kuo, Chin Chi ^c   Chang, Fang Chi ^c   Liao, Shih Cheng ^c   Hsieh, Bor Sen ^c   more..

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b LERNER RESEARCH INSTITUTE   (United States)

^c Yun Lin Branch ^*

Author keywords

131I; Adrenal adenoma; NP 59; Primary aldosteronism; SPECT CT

Indexed keywords

6BETA IODOMETHYL 19 NORCHOLEST 5(10) EN 3BETA OL I 131; DEXAMETHASONE; NP 69; UNCLASSIFIED DRUG; 6 IODOMETHYLCHOLESTEROL; 6-IODOMETHYLCHOLESTEROL; DIAGNOSTIC AGENT; DRUG DERIVATIVE; IODOCHOLESTEROL;

ADRENAL HYPERPLASIA; ADRENAL SCINTISCANNING; ADRENAL SUPPRESSION; ADRENALECTOMY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; PREOPERATIVE EVALUATION; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ADENOMA; ADRENAL GLAND; HYPERALDOSTERONISM; HYPERPLASIA; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; RADIOGRAPHY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; VASCULARIZATION; VEIN;

19-IODOCHOLESTEROL; ADENOMA; ADRENAL GLANDS; ADRENALECTOMY; ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERALDOSTERONISM; HYPERPLASIA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; VEINS;

EID: 70349638916     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.109.064873     Document Type: Article

References (30)

1. Kaplan NM. The current epidemic of primary aldosteronism: causes and consequences. J Hypertens. 2004;22:863-869. (Pubitemid 38680454)
2. Auda SP, Brennan MF, Gill JR Jr. Evolution of the surgical management of primary aldosteronism. Ann Surg. 1980;191:1-7. (Pubitemid 10140791)
3. Ferriss JB, Brown JJ, Fraser R, et al. Results of adrenal surgery in patients with hypertension, aldosterone excess, and low plasma renin concentration. Br Med J. 1975;18:135-138.
4. Lim PO, Young WF, Macdonald TM. A review of the medical treatment of primary aldosteronism. J Hypertens. 2001;19:353-361. (Pubitemid 32195369)
5. Patel SM, Lingam RK, Beconsfield TI, Tran TL, Brown B. Role of radiology in the management of primary aldosteronism. Radiographics. 2007;27:1145-1157.
6. Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B. Incidentally discovered adrenal masses. Endocr Rev. 1995;16:460-484.
7. Doppman JL, Gill JR Jr, Miller DL, et al. Distinction between hyperaldosteronism due to bilateral hyperplasia and unilateral aldosteronoma: reliability of CT. Radiology. 1992;184:677-682.
8. Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2008;93:3266-3281.
9. Rossi GP, Sacchetto A, Chiesura-Corona M, et al. Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J Clin Endocrinol Metab. 2001;86:1083-1090. (Pubitemid 32322986)
10. Sarkar SD, Beierwaltes WH, Ice RD, et al. A new and superior adrenal scanning agent, NP-59. J Nucl Med. 1975;16:1038-1042.
11. 131I-6β-iodomethyl-19-nor- cholesterol (NP-59): evaluation in humans. J Clin Endocrinol Metab. 1977;45:353-362.
12. Gross MD, Valk TW, Swanson DP, Thrall JH, Grekin RJ, Beierwaltes WH. The role of pharmacologic manipulation in adrenal cortical scintigraphy. Semin Nucl Med. 1981;11:128-148.
13. Gross MD, Freitas JE, Swanson DP, Brady T, Beierwaltes WH. The normal dexamethasone-suppression adrenal scintiscan. J Nucl Med. 1979;20:1131-1135.
14. Weinberger MH, Grim CE, Hollifield JW, et al. Primary aldosteronism: diagnosis, localization and treatment. Ann Intern Med. 1979;90:386-395. (Pubitemid 9125723)
15. Wu VC, Chueh SC, Chang HW, et al. Bilateral aldosterone-producing adenomas: differentiation from bilateral adrenal hyperplasia. QJM. 2008;101:13-22.
16. Liao CH, Chueh SC, Lai MK, Hsiao PJ, Chen J. Laparoscopic adrenalectomy for potentially malignant adrenal tumors greater than 5 centimeters. J Clin Endocrinol Metab. 2006;91:3080-3083. (Pubitemid 44271759)
17. Novitsky YW, Kercher KW, Rosen MJ, Cobb WS, Jyothinagaram S, Heniford BT. Clinical outcomes of laparoscopic adrenalectomy for lateralizing nodular hyperplasia. Surgery. 2005;138:1009-1017. (Pubitemid 41797339)
18. Catena C, Colussi G, Lapenna R, et al. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension. 2007;50:911-918. (Pubitemid 350287534)
19. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005;45:1243-1248. (Pubitemid 40523144)
20. Gross MD, Shapiro B, Grekin RJ, et al. Scintigraphic localization of adrenal lesions in primary aldosteronism. Am J Med. 1984;77:839-844. (Pubitemid 15204861)
21. Ikeda DM, Francis IR, Glazer GM, Amendola MA, Gross MD, Aisen AM. The detection of adrenal tumors and hyperplasia in patients with primary aldosteronism: comparison of scintigraphy, CT and MR imaging. AJR. 1989;153:301-306.
22. Kazerooni EA, Sisson JC, Shapiro B, et al. Diagnostic accuracy and pitfalls of [iodine-131]6-beta-iodomethyl-19-norcholesterol (NP-59) imaging. J Nucl Med. 1990;31:526-534. (Pubitemid 20144725)
23. Radin DR, Manoogian C, Nadler JL. Diagnosis of primary hyperaldosteronism: importance of correlating CT findings with endocrinologic studies. AJR. 1992;158:553-557.
24. Celen O, O'Brien MJ, Melby JC, Beazley RM. Factors influencing outcome of surgery for primary aldosteronism. Arch Surg. 1996;131:646-650. (Pubitemid 26175585)
25. Nocaudie-Calzada M, Huglo D, Lambert M, et al. Efficacy of iodine-131 6β-methyl-iodo-19-norcholesterol scintigraphy and computed tomography in patients with primary aldosteronism. Eur J Nucl Med. 1999;26:1326-1332. (Pubitemid 29467028)
26. Nomura K, Kusakabe K, Maki M, Ito Y, Aiba M, Demura H. Iodomethylnorcholesterol uptake in an aldosteronoma shown by dexamethasone-suppression scintigraphy: relationship to adenoma size and functional activity. J Clin Endocrinol Metab. 1990;71:825-830. (Pubitemid 20312087)
27. Ishimura J, Kawanaka M, Fukuchi M. Clinical application of SPECT in adrenal imaging with iodine-131 6β-iodomethyl-19-norcholesterol. Clin Nucl Med. 1989;14:278-281. (Pubitemid 19105355)
28. 131I-6β-iodomethyl-norcholesterol uptake to discriminate subclinical and preclinical functioning adrenal incidentaloma. J Nucl Med. 2003;44:1057-1064.
29. Hwang I, Balingit AG, Georgitis WJ, Sisson JC, Shapiro B. Adrenocortical SPECT using iodine-131 NP-59. J Nucl Med. 1998;39:1460-1463. (Pubitemid 28373579)
30. Hollak CEM, Prummel MF, Tiel-Van Buul MMC. Bilateral adrenal tumours in primary aldosteronism: localization of a unilateral aldosteronoma by dexamethasone suppression scan. J Intern Med. 1991;229:545-548.